Amylyx Pharmaceuticals, Inc.
AMLX
DELAYED 1 MONTH

16 insider filings · Latest: Jun 4, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
May 21, 2026May 26 8:00 PMKaren FirestoneDirector
Purchase
3,800$13.51$51.3K66,900(D)

View →

Mar 2, 2026Mar 4 9:00 PMJustin B. KleeDirector, Co-Chief Executive Officer
Sale
29,282$14.47$423.8K3,334,616(D)

View →

Mar 2, 2026Mar 4 9:00 PMJoshua B CohenDirector, Co-Chief Executive Officer
Sale
29,282$14.48$424.1K3,334,683(D)

View →

Mar 2, 2026Mar 4 9:00 PMCamille L BedrosianChief Medical Officer
Sale
6,461$14.58$94.2K169,295(D)

View →

Mar 2, 2026Mar 4 9:00 PMJames M FratesChief Financial Officer
Sale
7,909$14.52$114.9K165,638(D)

View →

Mar 2, 2026Mar 4 9:00 PMGina MazzarielloChief Legal Officer
Sale
6,844$14.52$99.4K134,430(D)

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jun 4, 2026Jun 8 8:00 PMBernhardt G ZeiherDirector
Grant/Award
24,372$14.3124,372(D)

View →

Jun 4, 2026Jun 8 8:00 PMKaren FirestoneDirector
Grant/Award
24,372$14.3124,372(D)

View →

Jun 4, 2026Jun 8 8:00 PMDaphne QuimiDirector
Grant/Award
24,372$14.3124,372(D)

View →

Jun 4, 2026Jun 8 8:00 PMGeorge M Milne JRDirector
Grant/Award
24,372$14.3124,372(D)

View →

Jun 4, 2026Jun 8 8:00 PMPaul R. FonteyneDirector
Grant/Award
24,372$14.3124,372(D)

View →

Mar 5, 2026Mar 9 8:00 PMJoshua B CohenDirector, Co-Chief Executive Officer
Grant/Award
373,295$14.10373,295(D)

View →

Mar 5, 2026Mar 9 8:00 PMGina MazzarielloChief Legal Officer
Grant/Award
111,990$14.10111,990(D)

View →

Mar 5, 2026Mar 9 8:00 PMJames M FratesChief Financial Officer
Grant/Award
143,985$14.10143,985(D)

View →

Mar 5, 2026Mar 9 8:00 PMJustin B. KleeDirector, Co-Chief Executive Officer
Grant/Award
373,295$14.10373,295(D)

View →

Mar 5, 2026Mar 9 8:00 PMCamille L BedrosianChief Medical Officer
Grant/Award
143,985$14.10143,985(D)

View →